Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
|
|
F-star Therapeutics, Inc. (SBPH)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/24/2021 |
4/A
| Bermingham Nessan (Director) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Granted 16,875 shares
@ $0 |
|
| 08/24/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 08/24/2021 |
4/A
| Kayitalire Louis (Chief Medical Officer) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Granted 26,437 shares
@ $0 |
|
| 10/11/2016 |
4/A
| Eichler Kurt M (Director) has filed a Form 4 on Spring Bank Pharmaceuticals, Inc.|
Txns:
| Exercised (in-or-at-the-money) 9,375 shares
@ $8, valued at
$75k
Exercised (in-or-at-the-money) 10,416 shares
@ $9, valued at
$93.7k
|
|
| 08/16/2016 |
4/A
| Afdhal Nezam H. (Chief Medical Officer) has filed a Form 4 on Spring Bank Pharmaceuticals, Inc. |
|
|